Related references
Note: Only part of the references are listed.Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis
Yee Hui Yeo et al.
GASTROENTEROLOGY (2019)
Biology and regulation of IL-2: from molecular mechanisms to human therapy
Rosanne Spolski et al.
NATURE REVIEWS IMMUNOLOGY (2018)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
IP-10 Expression in Patients with Chronic HBV Infection and Its Ability to Predict the Decrease in HBsAg Levels after Treatment with Entecavir
Kai Zhao et al.
MOLECULES AND CELLS (2017)
Serum interferon-inducible protein 10 levels predict hepatitis B s antigen seroclearance in patients with chronic hepatitis B
G. L. -H. Wong et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
HLA-DP and IL28B Polymorphisms: Influence of Host Genome on Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B
Wai-Kay Seto et al.
CLINICAL INFECTIOUS DISEASES (2013)
Clinical and Virological Characteristics Post HBsAg Seroclearance in Hepatitis B Virus Carriers With Hepatic Steatosis Versus Those Without
Chia-Ming Chu et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen-negative patients with chronic hepatitis B
Pietro Lampertico et al.
HEPATOLOGY (2013)
Circulating Chemokine (C-X-C Motif) Receptor 5+CD4+ T Cells Benefit Hepatitis B e Antigen Seroconversion Through IL-21 in Patients With Chronic Hepatitis B Virus Infection
Yongyin Li et al.
HEPATOLOGY (2013)
Reduction of Hepatitis B Surface Antigen Levels and Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B Patients Receiving 10 Years of Nucleoside Analogue Therapy
Wai-Kay Seto et al.
HEPATOLOGY (2013)
Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy
Wei Liao et al.
IMMUNITY (2013)
Serum levels of interferon-gamma-inducible protein 10 and response to peginterferon therapy in HBeAg-positive chronic hepatitis B
Milan J. Sonneveld et al.
JOURNAL OF HEPATOLOGY (2013)
IL28B Polymorphism Correlates with Active Hepatitis in Patients with HBeAg-Negative Chronic Hepatitis B
I-Cheng Lee et al.
PLOS ONE (2013)
HBcAg-Specific IL-21-Producing CD4+T Cells are Associated with Relative Viral Control in Patients with Chronic Hepatitis B
L. Li et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2013)
High serum IL-21 levels after 12 weeks of antiviral therapy predict HBeAg seroconversion in chronic hepatitis B
Shi-Wu Ma et al.
JOURNAL OF HEPATOLOGY (2012)
Hepatitis B surface antigen (HBsAg) decrease and serum interferon-inducible protein-10 levels as predictive markers for HBsAg loss during treatment with nucleoside/nucleotide analogues
Jerzy Jaroszewicz et al.
ANTIVIRAL THERAPY (2011)
Serum Levels of Interleukin-10 and Interleukin-12 Predict Early, Spontaneous Hepatitis B Virus e Antigen Seroconversion
Jia-Feng Wu et al.
GASTROENTEROLOGY (2010)
Geographical and genetic diversity of the human hepatitis B virus
Fuat Kurbanov et al.
HEPATOLOGY RESEARCH (2010)
Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays
Wilco de Jager et al.
BMC IMMUNOLOGY (2009)
Long-term Outcome of Hepatitis B e Antigen-Negative Hepatitis B Surface Antigen Carriers in Relation to Changes of Alanine Aminotransferase Levels Over Time
Dar-In Tai et al.
HEPATOLOGY (2009)
HBsAg seroclearance in chronic hepatitis B in Asian patients: Replicative level and risk of hepatocellular carcinoma
Man-Fung Yuen et al.
GASTROENTEROLOGY (2008)
Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection
Juan R. Larrubia et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
The role of CCR5/CXCR3 expressing CD8+cells in liver damage and viral control during persistent hepatitis C virus infection
Juan-Ramon Larrubia et al.
JOURNAL OF HEPATOLOGY (2007)
Does increased body mass index with hepatic steatosis contribute to seroclearance of hepatitis B virus (HBV) surface antigen in chronic HBV infection?
C-M Chu et al.
INTERNATIONAL JOURNAL OF OBESITY (2007)
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection
Richard K. Sterling et al.
HEPATOLOGY (2006)
Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection
YF Liaw et al.
GASTROENTEROLOGY (2004)
Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients
JM Sánchez-Tapias et al.
GASTROENTEROLOGY (2002)
Identification of a candidate regulatory region in the human CD8 gene complex by colocalization of DNase I hypersensitive sites and matrix attachment regions which bind SATB1 and GATA-3
LJ Kieffer et al.
JOURNAL OF IMMUNOLOGY (2002)
Blocking chemokine responsive to γ-2/interferon (IFN)-γ inducible protein and monokine induced by IFN-γ activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes
K Kakimi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Serologic and clinical outcomes of 1536 Alaska natives chronically infected with hepatitis B virus
BJ McMahon et al.
ANNALS OF INTERNAL MEDICINE (2001)
Increase of chemokine interferon-inducible protein-10 (IP-10) in the serum of patients with autoimmune liver diseases and increase of its mRNA expression in hepatocytes
K Nishioji et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2001)
Share Paper
